Experience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment

Experience with cinacalcet in primary hyperparathyroidism: results after 1 year of treatment

Objectives: To assess the characteristics of patients with primary hyperparathyroidism (PHPT) treated with cinacalcet and to evaluate its efficacy in reducing serum calcium and parathyroid hormone (PTH) concentrations after 1 year of treatment. Methods: The study included 20 patients with PHPT who h...

Full description

Bibliographic Details
Main Authors:	Inés Luque-Fernández, Antonia García-Martín, Alessandra Luque-Pazos
Format:	Article
Language:	English
Published:	SAGE Publishing 2013-06-01
Series:	Therapeutic Advances in Endocrinology and Metabolism
Online Access:	https://doi.org/10.1177/2042018813482344

Similar Items

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
by: Giulia Di Dalmazi, et al.
Published: (2018-12-01)

Cinacalcet effect on severe hyperparathyroidism
by: Al Saran Khalid, et al.
Published: (2010-01-01)

CINACALCET IN TREATMENT OF HYPERPARATHYROIDISM IN RECIPIENTS OF RENAL GRAFT
by: O. N. Vetchinnikova, et al.
Published: (2014-05-01)

Cinacalcet in treatment of the secondary hyperparathyroidism relapse in patients on dialysis
by: Olga Vetchinnikova, et al.
Published: (2012-06-01)

Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience
by: Julie Bernardor, et al.
Published: (2022-08-01)

A single-centre retrospective analysis of cinacalcet therapy in primary hyperparathyroidism
by: Daniel Bell, et al.
Published: (2021-11-01)

PHARMACOECONOMIC EVALUATION OF TREATMENT OF SECONDARY HYPERPARATHYROIDISM IN PATIENTS ON DIALYSIS WITH CINACALCET
by: R. I. Yagudina, et al.
Published: (2015-03-01)

The conundrum of parathyroidectomy vs cinacalcet for treatment of post-transplant hyperparathyroidism
by: Rima Patel, et al.
Published: (2020-08-01)

Role of cinacalcet in the treatment of secondary hyperparathyroidism in chronic kidney disease
by: H.K. Aggarwal, et al.
Published: (2013-09-01)

Effectiveness of cinacalcet treatment for secondary hyperparathyroidism on hospitalization: Results from the MBD-5D study.
by: Shinji Asada, et al.
Published: (2019-01-01)

Cinacalcet-Associated Resolution of Primary Hyperparathyroidism in a Patient With Normal Kidney Function
by: Son Nguyen DO, PharmD, et al.
Published: (2020-06-01)

Cinacalcet versus Parathyroidectomy in the Treatment of Secondary Hyperparathyroidism Post Renal Transplantation
by: Soliman Amin R., et al.
Published: (2016-09-01)

THE CARDIOVASCULAR EFFECTS OF CINACALCET IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM
by: Sungjin Chung, et al.
Published: (2012-06-01)

Use of cinacalcet for the management of hyperparathyroidism in patients with different degrees of renal failure
by: José M. Orellana, et al.
Published: (2016-03-01)

Parathyroidectomy versus cinacalcet in the treatment of tertiary hyperparathyroidism after kidney transplantation: a retrospective study
by: Suyun Jung, et al.
Published: (2022-07-01)

Use of cinacalcet in nephrolithiasis associated with normocalcemic or hypercalcemic primary hyperparathyroidism: results of a prospective randomized pilot study
by: Simone Brardi, et al.
Published: (2015-03-01)

Use of Cinacalcet in the treatment of persistent hyperparathyroidism post-renal transplant. A single center experience in Argentina
by: Jorge Camacho, et al.
Published: (2017-06-01)

Management of pre-renal transplant secondary hyperparathyroidism: parathyroidectomy versus cinacalcet
by: Muhammed Ahmed Elhadedy, et al.
Published: (2023-04-01)

Cinacalcet for Severe Secondary Hyperparathyroidism in Children with End-stage Kidney Disease
by: Areej Adel Sheerah, et al.
Published: (2021-01-01)

Cost-effectiveness analysis of cinacalcet vs. paricalcitol in the treatment of hyperparathyroidism secondary to chronic kidney disease
by: Daniela Ponce, et al.
Published: (2023-04-01)

Cinacalcet for Management of Tertiary Hyperparathyroidism Associated with Chronic Treatment of Hypophosphatemia in an Adult with Tumor-Induced Osteomalacia
by: Sophia Hu, MD, et al.
Published: (2015-01-01)

The Effectiveness of Alternate-day Cinacalcet Therapy for Secondary Hyperparathyroidism in Noncompliant Hemodialysis Patients
by: Mohammed Al-Homrany, et al.
Published: (2022-01-01)

Cinacalcet use in secondary hyperparathyroidism: a machine learning-based systematic review
by: Xiaosong Li, et al.
Published: (2023-07-01)

The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism
by: Sérgio Gardano Elias Bucharles, et al.

Effectiveness of Cinacalcet in Patients with Chronic Kidney Disease and Secondary Hyperparathyroidism Not Receiving Dialysis.
by: Ariadna Pérez-Ricart, et al.
Published: (2016-01-01)

Gallstones were associated with the gastrointestinal adverse events of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
by: Keiichi Otsuka, et al.
Published: (2018-10-01)

Cinacalcet adherence in dialysis patients with secondary hyperparathyroidism in Lombardy Region: clinical implications and costs
by: Alessandro Roggeri, et al.
Published: (2020-03-01)

A case of hyperparathyroidism-associated parkinsonism successfully treated with cinacalcet hydrochloride, a calcimimetic
by: Yuichiro Ohya, et al.
Published: (2018-05-01)

Inicial experience with cinacalcet in Argentina
by: Elisa Elena Del Valle, et al.
Published: (2015-01-01)

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
by: Luciano Artur Lopes Pereira, et al.
Published: (2023-03-01)

Etelcalcetide controls secondary hyperparathyroidism and raises sclerostin levels in hemodialysis patients previously uncontrolled with cinacalcet
by: Luciano Artur Lopes Pereira, et al.
Published: (2023-03-01)

Effect of switching from cinacalcet to etelcalcetide on secondary hyperparathyroidism in patients undergoing hemodialysis: an ESCORT trial
by: Yuka Kurokawa, et al.
Published: (2020-12-01)

Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019-06-01)

Three Therapeutic Strategies: Cinacalcet, Paricalcitol or Both in Secondary Hyperparathyroidism Treatment in Hemodialysed Patients During 1-Year Observational Study—A Comparison
by: Jacek Zawierucha, et al.
Published: (2019-02-01)

Efficacy of low-dose cinacalcet on alternate days for the treatment of secondary hyperparathyroidism in hemodialysis patients: a single-center study
by: Gojaseni P, et al.
Published: (2017-02-01)

Changes of Serum Total and Free Testosterone Concentrations in Male Chronic Hemodialysis Patients with Secondary Hyperparathyroidism in Response to Cinacalcet Treatment
by: Piotr Kuczera, et al.
Published: (2016-01-01)

Successful treatment of early allograft dysfunction with cinacalcet in a patient with nephrocalcinosis caused by severe hyperparathyroidism: a case report
by: Boonyarit Cheunsuchon, et al.
Published: (2017-04-01)

The effectiveness of cinacalcet: a randomized, open label study in chronic hemodialysis patients with severe secondary hyperparathyroidism
by: Paweena Susantitaphong, et al.
Published: (2019-01-01)

Experience of diagnostics and surgical treatment primary hyperparathyroidism
by: Igor V. Makarov, et al.
Published: (2017-09-01)

P9.01 CINACALCET MAY REDUCE ARTERIAL STIFFNESS IN PATIENTS WITH CHRONIC RENAL DISEASE AND SECONDARY HYPERPARATHYROIDISM – RESULTS OF A SMALL-SCALE, PROSPECTIVE, OBSERVATIONAL STUDY
by: J. Bonet, et al.
Published: (2011-11-01)